Analyst downgrades weigh on drug stocks
April 29, 2011 at 11:10 AM EDT
Shares of Regeneron, Curis and Endo Pharmaceuticals are falling in early trading following analyst downgrades.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.